Non-ALCL subtype, intermediate/high-risk IPI, and detectable EBV-DNA, as well as mutations in CREBBP, IDH2, and ARID1B, were associated with inferior PFS and OS, while mutations in KMT2D were associated only with inferior PFS (Additional file 1: Table S3). Here, ARID1B is linked to anaplastic large cell lymphoma.